Ellipses Pharma
Clinical trials sponsored by Ellipses Pharma, explained in plain language.
-
New hope for advanced breast cancer: EP0062 trial begins
Disease control Recruiting nowThis study tests a new drug called EP0062 in people with advanced breast cancer that has come back after treatment. The goal is to find the best dose and see if it is safe and works, either alone or with other standard treatments. About 95 adults with a specific type of breast ca…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated May 26, 2026 07:23 UTC
-
New pill targets hard-to-treat cancers with RET mutation
Disease control Recruiting nowThis study tests a new drug, EP0031, in 265 adults with advanced cancers (like lung cancer) that have a specific RET gene change. The goal is to see if the drug is safe and shrinks tumors. Participants take the drug by mouth, and doctors monitor side effects and how well it works…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
New hope for hard-to-treat blood cancers? early trial begins.
Disease control Recruiting nowThis study tests a new experimental drug called EP0042, alone or with other cancer treatments, in adults with advanced acute myeloid leukemia (AML) or related blood cancers. The main goal is to find a safe dose that might work against the cancer. About 70 people will take part in…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated May 18, 2026 12:08 UTC